Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05181722 · ClinicalTrials.gov registry record · NA

Evaluating the Use of Patient Navigation to Promote Timely Diagnostic Evaluation During the COVID-19 Pandemic

A NA study of Breast Cancer, sponsored by Johns Hopkins University.

Active
Registry status
NA
Development phase
196
Enrollment target
1
Study location

NCT05181722: Active NA study of Breast Cancer, sponsored by Johns Hopkins University.

NCT05181722 is a NA study of Breast Cancer that is active but no longer recruiting, run by Johns Hopkins University. The registered enrollment target is 196 participants, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT05181722, a NA study of Breast Cancer, is active but no longer recruiting, sponsored by Johns Hopkins University.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
196 participants
Enrollment target
1
Study location

Study Summary

The primary objective of this project is to evaluate the role of patient navigation in promoting timely follow-up of abnormal breast imaging findings in patient populations that have been most severely impacted by the novel coronavirus (COVID-19) pandemic. This project aims to assess the impact of patient navigation as an intervention tool in patient populations that are most at risk for delayed follow-up. The investigators hypothesize that patient navigation services may be an effective way to mitigate the impact of the pandemic by decreasing the risk of a delayed breast cancer diagnosis and promoting timely diagnostic follow-up.

Primary Outcome

The follow-up rates for patients with an abnormal screening mammogram will be calculated. This will be expressed as the percentage of patients who follow-up within 30 days after the abnormal screening mammogram.

Conditions Studied

Interventions

  • OTHER Patient navigator support

Study Locations (1)

Maryland

  • Johns Hopkins Breast Imaging clinics - Baltimore

Trial Details

FieldValue
Enrollment Target 196 participants
Start Date 2022-07-18
Est. Completion 2026-12
Phase NA
Johns Hopkins University

1,448 total trials

What the registry record for NCT05181722 still lists

NCT05181722 is an interventional study that assigns participants to a tested intervention. The registered 196 participants enrollment target is mid-sized for trials with a published cap, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (93% lower).

The record links to 1 condition, with Breast Cancer appearing as the primary indexed condition, and to 1 intervention - of which Patient navigator support is the first listed.

NCT05181722 reports a single indexed study location in Maryland.

Frequently Asked Questions

What is clinical trial NCT05181722 about?

NCT05181722 is a clinical study titled "Evaluating the Use of Patient Navigation to Promote Timely Diagnostic Evaluation During the COVID-19 Pandemic". The primary objective of this project is to evaluate the role of patient navigation in promoting timely follow-up of abnormal breast imaging findings in patient populations that have been most severely impacted by the novel coronavirus (COVID-19) pandemic. This project aims to assess the impact of p...

What is the current status of trial NCT05181722?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 196 participants. The study started on 2022-07-18. Estimated completion is 2026-12.

What conditions does trial NCT05181722 study?

This clinical trial studies the following conditions: Breast Cancer.

What interventions are being tested in trial NCT05181722?

The interventions under investigation include: Patient navigator support (OTHER).

Who is sponsoring clinical trial NCT05181722?

This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05181722 being conducted?

This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Breast Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05181722's enrollment target sits among peer trials

196 386th of 1224 higher than 839 of 1,224 other Breast Cancer trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Breast Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02822768 · 196 participants · NA

    Packing Versus no Packing for Cutaneous Abscess

  • NCT04250259 · 196 participants · Phase 2

    SAMe Trial for Patients With Alcoholic Cirrhosis

  • NCT05142592 · 196 participants · Phase 1

    Phase1/2a Study for IPG7236 in Patients With Advanced Solid Tumors

  • NCT05317832 · 196 participants · Phase 2

    Using Smartphones to Improve Physical Activity Levels of Individuals With Spinal Cord Injury

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05181722, the US trial registry maintained by the National Library of Medicine. NCT05181722 (mid enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.